BIO-key International Inc. (NASDAQ:BKYI) Stock Short Interest Jumps 14,917.0%

BIO-key International Inc. (NASDAQ:BKYI) was the target of a significant growth in short interest during the month of September. As of September 30th, there was short interest totaling 995,329 shares, a growth of 14,917.0% from the September 15th total of 6,628 shares. Approximately 72.2% of the shares of the company are sold short. Based on an average daily volume of 15,350,267 shares, the short-interest ratio is currently 0.1 days.

Analyst Ratings Changes

Several research analysts have weighed in on the company. Zacks Research upgraded BIO-key International to a “hold” rating in a research note on Thursday, August 6th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BIO-key International in a research report on Friday, July 17th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, BIO-key International currently has a consensus rating of “Reduce”.

BIO-key International Price Performance

Shares of BIO-key International stock opened at $1.67 on Friday. The stock has a market capitalization of $2.40 million, a P/E ratio of -0.41 and a beta of 0.50. BIO-key International has a 12 month low of $1.61 and a 12 month high of $19.70. The business has a 50 day simple moving average of $2.85 and a two-hundred day simple moving average of $4.18.

BIO-key International (NASDAQ:BKYI) last posted its quarterly earnings results on Thursday, August 13th. The technology company reported ($0.56) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.82) by $0.26. The business had revenue of $1.92 million during the quarter, compared to analyst estimates of $1.80 million. BIO-key International had a negative return on equity of 67.31% and a negative net margin of 50.01%. As a group, research analysts anticipate that BIO-key International will post -1.62 EPS for the current fiscal year.

BIO-key International Company Profile

BIO-key International, Inc (NASDAQ: BKYI) develops biometric identity and access-management solutions. Its technology enables organizations to authenticate users through fingerprints and other biometric credentials, helping replace or supplement passwords while supporting secure access to applications, networks and devices.

The company’s offerings include biometric readers and software, as well as identity and access-management platforms such as PortalGuard and WEB-key. These products are designed to support multifactor authentication, single sign-on, password management and identity verification across on-premises and cloud-based environments.

BIO-key serves businesses, government agencies, educational institutions and other organizations that require secure user authentication.